alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model.
S Thaisrivongs, D T Pals, J A Lawson, S R Turner, D W Harris
Index: J. Med. Chem. 30(3) , 536-41, (1987)
Full Text: HTML
Abstract
A structure-activity analysis of peptides containing backbone C alpha-methyl modification at the P4 site of the angiotensinogen sequence led to the discovery of potent renin inhibitors with apparent in vitro metabolic stability. Boc-alpha-MePro-Phe-His-Leu psi[CHOHCH2]Val-Ile-Amp dicitrate (Va) is a potent inhibitor of human plasma renin with an IC50 value of 1.8 nM. This peptide was shown not to be degraded in vitro by chymotrypsin, elastase, pepsin, and a rat liver homogenate preparation. It is also a potent inhibitor of hog renin with an IC50 value of 1.6 nM and was shown to elicit in vivo activity and cause dose-dependent hypotensive responses when given intravenously to anesthetized ganglion-blocked, hog renin infused rats.
Related Compounds
Related Articles:
Effects of ring contraction on the conformational preferences of α-substituted proline analogs.
2012-01-01
[Biopolymers 98(2) , 98-110, (2012)]
Beta-turns induced in bradykinin by (S)-alpha-methylproline.
1992-02-10
[FEBS Lett. 297(3) , 216-20, (1992)]
1995-01-01
[Life Sci. 57(24) , 2245-52, (1995)]
1997-07-01
[J. Pept. Res. 50(1) , 1-13, (1997)]
Is the backbone conformation of C(alpha)-methyl proline restricted to a single region?
2009-08-10
[Chemistry 15(32) , 8015-25, (2009)]